宫颈鳞状细胞癌组织中Bcl-2与血管内皮生长因子的表达及相关性(3)
第1页 |
参见附件(3068KB,3页)。
[3] Riedel F, Gotte K, Bergler W, et al. Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol Rep, 2001:471-476.
[4] Hockenbery D M, Zutter M, Hickey W, et al. Bcl-2 Protein is topographically restricted in tissue characterized apoptotic cell death. Proc Natl Acad Sci USA, 2001:3619.
[5] 齐荣义,王慧,栾梅.人宫颈bcl-2基因表达与预后的关系.中国实用妇科与产科杂志,2000,16(6):349-351.
[6] Tjalma WA,Weyler JJ,Bogers JJ.The importance of biological factors(bcl-2,bax,p53,PCNA,MI,HPV and angiogenesis)in invasive cervical.Cancer,2001,97(2):223-230.
[7] Carmeliet P,Ferreira V,Breier G,et al. Abnomoral blood vessles development and lethality in embroyos lacking a single VEGF allclc. Nature,1996,435-443.
[8] 王琳,陈功泉.宫颈癌组织中VEGF 和nm23-H1表达及临床意义.中国现代医学杂志,2005,15(20):3093-3095,3098.
[9] Boocock CA,Charnock-Jones DS,Sharkey AM, et al.Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.J Natl Cancer Inst,1995,87(7):506-516.
[10] Hata S,Fukuo K,Morimoto S,et al. Vascular smooth matains the levels of bcl-2 in endothelial cells. Atherosclerosis,2001:309-316.
[11] Pidgeon G P,Barr M P,Harmey J H,et al. Vascular endothelial growth factor (VEGF) upregulates bcl-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. British Journal of Cancer,2001:273-278.
注:本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页,详见PDF附件(3068KB,3页)。